SPONSOR
Centre Hospitalier Princesse Grace
Total Trials
2
Recruiting
2
Phases
N/A
Centre Hospitalier Princesse Grace is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Rheumatoid Arthritis (RA), Traumatic Brain Injury.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Hospitalier Princesse Grace
How many clinical trials has Centre Hospitalier Princesse Grace sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Centre Hospitalier Princesse Grace, of which 2 are actively recruiting participants. These trials cover conditions including Rheumatoid Arthritis (RA), Traumatic Brain Injury. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Hospitalier Princesse Grace research focus on?
Centre Hospitalier Princesse Grace clinical trials span Rheumatoid Arthritis (RA), Traumatic Brain Injury. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Centre Hospitalier Princesse Grace clinical trial?
To participate in a Centre Hospitalier Princesse Grace trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Hospitalier Princesse Grace trials with current recruitment status updated daily.
Clinical Trials by Centre Hospitalier Princesse Grace
NCT07674134
Recruiting
Comparison of Oral Administration of a JAK Inhibitor in Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
NCT05885529
Recruiting
Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries
Traumatic Brain Injury
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology